Evaluation of knowledge and attitudes among intensive care physicians during the COVID-19 pandemic
a cross- sectional survey
Palavras-chave:
COVID-19 [supplementary concept], Intensive care units, Pandemics, Airway management, Healthcare surveys, AnesthesiologyResumo
BACKGROUND: The novel coronavirus (COVID-19) emerged in Wuhan, China, in December 2019. OBJECTIVES: To evaluate the knowledge of intensive care physicians in Turkey about COVID-19 and their attitudes towards the strategies and application methods to be used for COVID-19 cases that need to be followed up in an intensive care unit, and to raise awareness about this issue. DESIGN AND SETTING: The population for this descriptive study comprised clinicians working in a variety of healthcare organizations in Turkey who provide monitoring and treatment within the intensive care process for COVID-19 patients. METHODS: Data were collected online using a survey form on the SurveyMonkey website between April 20 and April 25, 2020. RESULTS: The mean age of the 248 intensive care clinicians participating in the study was 37.2 ± 13.7 years and 49.19% were female. High rates of classical laryngoscope use were observed, especially among clinicians employed in state hospitals. Among all the participants, 54.8% stated that they were undecided about corticosteroid treatment for patients who had been intubated due to COVID-19. CONCLUSIONS: Many medications and methods are used for COVID-19 treatment. All national science committees are attempting to create standard treatment protocols. For intensive care treatment of COVID-19 patients, many factors require management, and clinicians’ experience is guiding future processes. We believe that this study will create awareness about this topic and contribute to the creation of standard treatment algorithms and the provision of better and safer healthcare services for this patient group.
Downloads
Referências
McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci USA. 1967;57(4):933-40. PMID: 5231356; doi: 10.1073/pnas.57.4.933.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. PMID: 32171076; doi: 10.1016/S0140-6736(20)30566-3.
Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020;382(19):1787-99. PMID: 32187464; doi: 10.1056/NEJMoa2001282.
Dong X, Cao YY, Lu XX, et al. Eleven Faces of Coronavirus Disease 2019 [published online ahead of print, 2020 Mar 20]. Allergy. 2020;10.1111/all.14289. doi: 10.1111/all.14289.
Wey WE, Li Z, Chiew KJ, et al. Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411-5. PMID: 32271722; doi: 10.15585/mmwr.mm6914e1.
Republic of Turkey Ministry of Health’s COVID-19 Guide. Yeni Koronavirüs Hastalığı (COVID-19). Available from: Available from: https://covid19bilgi.saglik.gov.tr/tr/ Accessed in 2020 (Jun 8).
World Health Organization. Coronavirus disease (COVID-19) pandemic. Coronavirus disease (COVID-2019) situation reports. Available from: Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ Accessed in 2020 (Jun 8).
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. PMID: 32113704; doi: 10.1016/j.jaut.2020.102433.
Centers for Disease Control and Prevention [website]. Coronavirus Disease 2019 (COVID-19). Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19). Available from: Available from: https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html Accessed in 2020 (Jun 8).
Türk Anesteziyoloji ve Reanimasyon Derneği. Havayolu Yönetimi Bilimsel Kurulu. COVID-19 Şüpheli Veya Tanili Hastada Havayolu Yönetimi Önerileri [Turkish Society of Anesthesiology and Reanimation. Airway management recommendations for suspended or diagnostic COVID-19 patients]. Available from: Available from: http://www.tard.org.tr/assets/pdf/TARD-CORONA-ETI-ONERILERI.pdf Accessed in 2020 (Jun 8).
Dost B, Koksal E, Terzi Ö, et al. Attitudes of Anesthesiology Specialists and Residents Toward Patients Infected with the Novel Coronavirus (COVID-19): A National Survey Study. Surg Infect (Larchmt). 2020;21(4):350‐6. PMID: 32275463; doi: 10.1089/sur.2020.097.
Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-81. PMID: 32250385; doi: 10.1001/jama.2020.5394.
Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854-87. PMID: 32222812; doi: 10.1007/s00134-020-06022-5.
Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58-60. PMID: 32147628; doi: 10.5582/ddt.2020.01012.
Chen C, Zhang Y, Huang J, et al. Favipiravir versus Arbidol for COVID-19: a randomized clinical trial. medRxiv preprint. 2020. doi: 10.1101/2020.03.17.20037432.
Downloads
Publicado
Como Citar
Edição
Seção
Licença

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.